PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 64 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2013 | $30,000 | – | 11,957 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 4,800,000 | $15,168,000 | 5.18% |
| Avoro Capital Advisors LLC | 6,004,564 | $18,974,000 | 4.93% |
| DG Capital Management, LLC | 695,808 | $2,199,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 1,108,719 | $3,504,000 | 2.03% |
| Aisling Capital LLC | 2,010,000 | $6,352,000 | 1.12% |
| Broadfin Capital, LLC | 6,090,829 | $19,247,000 | 1.07% |
| KOPP INVESTMENT ADVISORS LLC | 375,293 | $1,186,000 | 0.64% |
| SEARLE & CO. | 172,500 | $545,000 | 0.56% |
| Elk Creek Partners, LLC | 1,864,515 | $5,892,000 | 0.48% |
| WALL STREET ASSOCIATES | 696,300 | $2,200,000 | 0.42% |